New Origin Labs TM
New Origin Labs is an ingredient innovation first company with a focus on procuring and developing ingredients that are disruptive and scientifically significant. Through the marriage of eastern and western technology, New Origin Labs finds and develops distinctive and effective solutions to address real problems not trends.
Patented Bioconversion
*
Clinically Validated
*
Peer-Reviewed Research
*
Targeted Solutions
DISRUPTIVE
SCIENCE
We combine time-tested Eastern traditions like botanical fermentation with Western bioconversion engineering. This unique fusion allows us to unlock potentials in natural ingredients that nature alone cannot fully deliver.
Health is biology, not a viral moment. We ignore fleeting trends to focus on ingredient innovations that address inevitable biological needs. If it cannot be measured, it does not matter to us.
What We Do
1
Discover
We scour the globe to identify raw botanical materials. By looking beyond the surface of generic ingredients, we uncover unique bioactive compounds that have been historically revered but technologically untapped. Our discovery process is “ingredient-first,” prioritizing biological potential over market trends.
2
Prove
We do not rely on folklore; we rely on data. Once an ingredient is discovered, we apply advanced Western engineering such as our patented bioconversion and fermentation technologies to unlock its full power. We rigorously test, refine, and clinically validate every compound to ensure it delivers statistically significant, reproducible results.
3
Deliver
We bridge the gap between potential and performance. We don’t just supply raw materials; we deliver stabilized, bio-optimized metabolites that bypass the body’s natural limitations. Our final products are pathway-independent solutions designed to solve fundamental health challenges with precision and 100% predictability.
Featured Ingredient
NOV8
We’ve moved beyond precursors. By combining the ancient art of botanical fermentation with patented Western bioconversion technology, NOV8™ delivers a stabilized, direct-to-body Nitric Oxide metabolite. It bypasses the body’s aging production mechanisms to deliver consistent, life-changing circulation, regardless of age or biology.
FEATURED INNOVATION:
NOV8™
The World’s First
Pathway-Independent
Nitric Oxide Solution
Why Nitric Oxide (NO)
Needs Innovation
Nitric Oxide is the master signaling molecule of the cardiovascular system. It is essential for relaxing blood vessels, regulating healthy blood pressure, and delivering oxygen to every cell in your body. It is the foundation of vitality but your body’s ability to produce it is not permanent. Scroll below to see why it needs innovation.
Decline In NO Production
Clinical research confirms a precipitous drop in Nitric Oxide availability as we age. As illustrated here, the body’s natural production remains stable in youth but enters a critical ‘Danger Zone’ around age 40. By this stage, the primary endothelial pathway degrades, causing production to plummet by up to 50%, creating a deficit that diet alone often cannot bridge.
Primary NO Production
The Nitric Oxide Synthase (NOS) Pathway is the primary source of Nitric Oxide (NO) production in our body. The NOS enzyme convert L – Arginine to Nitric Oxide. The efficacy of the NOS enzyme is dependent on oxygen, cofactors, Arginine, and healthy blood vessels.
Age Related Decline
As we age and body begins to naturally decline due to a build up oxidative stress, lifestyle choices, and genetics. The NOS enzyme ability to produce NO sharply declines even though our bodies naturally produce enough Arginine available for conversion to NO without a need for supplementation.
Secondary NO Production
Even this secondary pathway is not a guaranteed fix. It is strictly dependent on specific reductase enzymes and a healthy oral microbiome to convert dietary nitrates into Nitric Oxide. Variables like mouthwash use, antibiotics, or low stomach acid can destroy the necessary bacteria, breaking this chain and halting production entirely.
The Real Problem
The fundamental flaw in existing supplementation is Enzymatic Reliance. Older models rely on the conversion of nitrate or arginine via the host’s metabolic pathways. This creates a critical point of failure: if the host’s NOS enzymes or oral microbiome are compromised, which is common after age 40, the conversion process stalls, rendering these products largely ineffective.
